This finding was in line with previous studies that identified one PTPN11 mutation associated with inv(3) (q21q26), which was associated with a marker of poor prognosis in AML patients concerning future malignant transformation [26,42]. This evidence concerns the gene PTPN11 and acute myeloid leukemia.